AKS-452: The newest vaccine – COVID-19 shot developed by Beverly company reaches trial stage

AKS-452: The newest vaccine – COVID-19 shot developed by Beverly company reaches trial stage

A COVID-19 vaccine developed by a company in Beverly is being tested on volunteers in the Netherlands. Akston Biosciences announced this week that the first participants in a clinical trial have received doses of its vaccine, called AKS-452. The company is hoping to get approval from European regulators and then seek approval in the United States. Read more >>

Share this post